In the cryptocurrency space, information about the token with the ticker symbol “BIOB” is relatively complex, as it may refer to several different projects or concepts. At present, there are two main possibilities: one is a cryptocurrency associated with the “Bio Protocol” project, and the other may be confused with the stock ticker symbol “Bio-Rad Laboratories Class B.”
Bio Protocol (BIO) Overview
If “BIOB” refers to the “Bio Protocol” project, it represents a cryptocurrency initiative focused on the bio-intelligent Design-Build-Test-Learn (DBTL) cycle, aimed at driving innovation in synthetic biology and sustainable biomanufacturing.
Project Vision and Technology
- Bio-Intelligent DBTL Cycle: The Bio Protocol project aims to enhance the efficiency and accessibility of synthetic biology innovation by introducing the bio-intelligent DBTL cycle.
- Technical Applications: The project combines biological and mechanical technologies and methods to accelerate the maturation of new synthetic biology innovations.
- Practical Applications: Bio Protocol plans to demonstrate the potential of its bio-intelligent DBTL cycle by creating Pseudomonas putida production strains capable of producing high-value products such as terpenes, polyolefins, and methyl methacrylate—products that hold significant potential for reducing anthropogenic greenhouse gas emissions.
- AI Scientists and In-Depth Research: The project also incorporates features such as AI scientists, in-depth research, best-practice program models, and paper generation, with the goal of transforming research agents into scientists.
Market Performance and Trading Activity
- Trading Volume: According to CoinGecko data, as of July 4, 2026, Bio Protocol (BIO) had a 24-hour trading volume of approximately $20,250,824, representing a 36.60% increase from the previous day, indicating a recent uptick in market activity.
- Exchanges: The token is listed on several major exchanges.
- Price Forecast: Some analysts believe Bio Protocol (BIO) has the potential to grow 4x or even 7x and is expected to break through the $0.20 mark.
Confusion with the “BIO.B” Stock Ticker
It should be noted that “BIO.B” is also the ticker symbol for Bio-Rad Laboratories Class B shares listed on the New York Stock Exchange (NYSE).
Bio-Rad Laboratories Company Profile
- Business Scope: Bio-Rad Laboratories is a company headquartered in Hercules, California, that develops, manufactures, and sells life science and clinical diagnostic products and solutions.
- Major Markets: Its business is primarily divided into two major markets: clinical diagnostics (accounting for 60% of sales) and life sciences (accounting for 40% of sales).
- Geographic Distribution: The company operates globally, with major markets including the Americas (approximately 40%), Europe (approximately 30%), and Asia (approximately 30%).
- Shareholding: Bio-Rad holds approximately 33% of the shares in Sartorius, a supplier of laboratory and bioprocessing solutions specializing in single-use technologies for biopharmaceutical manufacturing.
Stock Market Performance
- Market Capitalization: As of May 27, 2026, Bio-Rad Laboratories Class B (BIO.B) had a market capitalization of $8.2 billion and is considered a mid-cap stock.
- Stock Price: As of May 27, 2026, the price of BIO.B rose to $304.15.
- Historical Price: Over the past three years, BIO.B has traded at a high of $427.11 and a low of $222.64.
- Recent Performance: Over the past year, BIO.B has underperformed the broader market slightly, with a return of +21.6%, compared to the S&P 500 Index (SPY)’s return of +30.9%. However, BIO.B has outperformed the market over the past three months and two weeks.
- Financial Condition: The company’s fundamentals are relatively sound, and it has high growth potential, but its valuation is considered on the high side.
Summary
In summary, “BIOB” may refer to the cryptocurrency project Bio Protocol, or it may be confused with the Class B stock ticker for Bio-Rad Laboratories.When searching for related information, be sure to clarify which entity is being referred to. If it is the cryptocurrency, Bio Protocol is dedicated to driving innovation in synthetic biology through the Bio-Intelligence DBTL cycle; if it is the stock, Bio-Rad Laboratories is a company with global influence in the life sciences and clinical diagnostics sectors.
